Crisaborole (trade name Eucrisa) is a non-steroidal topical ointment used to treat mild to moderate atopic dermatitis (eczema). It is applied to the affected area of skin twice daily for up to 4 weeks. The active ingredient in Crisaborole is an enzyme inhibitor, which works by blocking a specific enzyme (phosphodiesterase-4) involved in inflammation. This reduces the itching, redness, and inflammation associated with atopic dermatitis. Common side effects of Crisaborole include burning, stinging, and itching of the skin.
Crisaborole is a nonsteroidal topical medication used to treat mild-to-moderate atopic dermatitis, commonly known as eczema, in adults and children 2 years of age and older. It is sold under the brand name Eucrisa, among others.
It works by inhibiting an enzyme called phosphodiesterase 4 (PDE4), which helps reduce inflammation in the skin. Crisaborole is a relatively new medication that was first approved by the US Food and Drug Administration (FDA) in 2016.
Here are some of the key points about crisaborole:
- It is a non-steroidal medication, which means it does not contain steroids. Steroids can have side effects, such as thinning of the skin, so crisaborole may be a good option for people who cannot use steroids.
- It is applied topically to the skin twice a day.
- It is generally well-tolerated, with the most common side effects being burning or stinging at the application site.
- It is not a cure for eczema, but it can help to control symptoms and improve the quality of life for people with the condition.
If you are considering using crisaborole to treat your eczema, it is important to talk to your doctor to see if it is right for you.